Edition:
United Kingdom

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

4,950JPY
18 Jan 2018
Change (% chg)

¥-60 (-1.20%)
Prev Close
¥5,010
Open
¥5,030
Day's High
¥5,040
Day's Low
¥4,950
Volume
558,000
Avg. Vol
434,647
52-wk High
¥6,700
52-wk Low
¥4,950

Select another date:

Thu, Jan 4 2018

BRIEF-Sawai Pharmaceutical completes sale of 20 pct stake in Upsher-Smith Laboratories

* Says 20 percent stake in Upsher-Smith Laboratories LLC, which was wholly owned by co's unit SAWAI AMERICA, LLC, has been transferred to SUMITOMO CORP's wholly owned US-based unit Sumitomo Corporation of Americas, on Jan. 3

BRIEF- Sawai Pharmaceutical to issue new shares and to distribute treasury common stock

* Says it plans to issue 5 million new shares and to distribute 1 million shares of its treasury common stock through public offering

REFILE-TABLE-Sawai Pharmaceutical- 6-MTH group results

(Adds company forecast. Accounting policy for forecast is IFRS) Nov 13 (Reuters)- Sawai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2017 Sep 30, 2016 Mar 31, 2018 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 70.76 65.42

BRIEF-Sawai Pharmaceutical to sell 20 pct stake in SAWAI AMERICA for $211 mln

* Says it plans to sell 20 percent stake in a wholly owned U.S.-based unit SAWAI AMERICA INC to Sumitomo Corporation of Americas, a wholly owned unit of SUMITOMO CORPORATION, for $211 million (23.2 billion yen)

BRIEF-Upsher-Smith says parent co to manufacture migraine medication in Japan With AstraZeneca

* Upsher-Smith Laboratories says co's parent Sawai Pharmaceutical entered agreement with AstraZeneca to manufacture & market migraine medication in Japan​

REFILE-TABLE-Sawai Pharmaceutical-Q1 group results

(Adds company forecast. Accounting policy for forecast is IFRS) Aug 14 (Reuters)- Sawai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Jun 30, 2017 Jun 30, 2016 Mar 31, 2018 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 33.65 32.95 

Select another date: